MENU
+Compare
AUTL
Stock ticker: NASDAQ
AS OF
Aug 11, 12:53 PM (EDT)
Price
$2.49
Change
+$0.16 (+6.87%)
Capitalization
620.1M

AUTL Autolus Therapeutics plc Forecast, Technical & Fundamental Analysis

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AUTL with price predictions
Aug 08, 2025

AUTL sees MACD Histogram just turned negative

AUTL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on July 25, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for AUTL moved out of overbought territory on July 24, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AUTL as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUTL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AUTL broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for AUTL moved above the 200-day moving average on August 06, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AUTL advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where AUTL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.671) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). AUTL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (68.966) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AUTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AUTL is expected to report earnings to fall 11.58% to -22 cents per share on August 12

Autolus Therapeutics plc AUTL Stock Earnings Reports
Q2'25
Est.
$-0.23
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.10
Q2'24
Missed
by $0.03
The last earnings report on May 08 showed earnings per share of -25 cents, meeting the estimate of -25 cents. With 944.13K shares outstanding, the current market capitalization sits at 620.10M.
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSIQX13.790.07
+0.51%
State Street International Stock Sel K
FAPKX12.780.06
+0.47%
Fidelity Advisor Healthy Future C
FESCX10.540.04
+0.38%
First Eagle Small Cap Opportunity I
GLVNX80.800.26
+0.32%
Invesco Global Focus R
FDSVX66.72-0.72
-1.07%
Fidelity Growth Discovery

AUTL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-0.85%
OCUL - AUTL
49%
Loosely correlated
-0.73%
CRSP - AUTL
47%
Loosely correlated
-1.72%
IPSC - AUTL
45%
Loosely correlated
-4.14%
SCPH - AUTL
45%
Loosely correlated
-7.58%
ERAS - AUTL
45%
Loosely correlated
-4.11%
More